doi: 10.3389/ftox.2025.1426132 Received 30 April 2024 Accepted 13 January 2025 Published 21 February 2025 Volume 7 - 2025 Edited by Stina Oredsson, Lund University, Sweden Reviewed by Robert Landsiedel, BASF, Germany Lan Ma-Hock, BASF, Germany Cynthia Bosquillon, University of Nottingham, United Kingdom Louis Scott, ImmuONE, United Kingdom Updates Copyright 2025 de vila, Mller, Barlow, Middleton, Theiventhran, Basili, Bowden, Saib, Engi, Pietrenko, Wallace, Boda, Constant, Behrsing, Patel and Baltazar
The amount varies depending on your starting weight, but real-world outcomes commonly range from 25 to 50 pounds or more over time
Neither name carries regulatory meaning, neither is a standardized formulation across the industry, and the ratios can vary between suppliers even under the same blend name
People new to GLP-1 therapy, those who tend to be sensitive to medications generally, and patients with mild to moderate obesity
BRAND NAMES Ozempic, Wegovy